Bradley Sumrow

Bradley Sumrow: Email & Phone Number

Opt-Out
Vice President, Clinical Development at Crescent Biopharma|Gaithersburg, Maryland, United States

Position:

Vice President, Clinical Development at Crescent Biopharma

Location:

Gaithersburg, Maryland, United States

LinkedIn
View Bradley Sumrow's Email
Up to 10 free lookups. No credit card required.
Last updated: 2025-09-08
Updated: 2025-09-08

Found email addresses for Bradley Sumrow:

Business emails:
Personal emails:
s***@mersana.com,
b***@gmail.com,
b***@yahoo.com

Found phone for Bradley Sumrow:

Searching for Bradley Sumrow profiles
0% completed

A different Bradley Sumrow?

Sign up to search for other Bradley Sumrow's across our 850M+ professionals database

Work Experience 24 years

Vice President, Clinical Development at Crescent Biopharma

Aug 2025 - Current

Executive Medical Director at Mersana Therapeutics

Mar 2023 - Aug 2025

Executive Medical Director at Calithera Biosciences

Dec 2021 - Jan 2023

Senior Director of Clinical Research at MacroGenics, Inc.

Mar 2021 - Dec 2021

Director of Clinical Research at MacroGenics, Inc.

May 2018 - Mar 2021

Medical Director, Clinical Development & Pharmacovigilance at MacroGenics, Inc.

Jul 2017 - May 2018

Product Safety Scientist at MacroGenics, Inc.

Nov 2015 - Jul 2017

Pharmacovigilance Scientist at Dendreon

Mar 2014 - Jun 2015

Resident Physician, Anesthesiology at UNC Health

Jun 2010 - Jan 2014

MRI Technologist at WakeMed

Aug 2005 - May 2006

Information Technology Support Specialist at UNC Kenan-Flagler Business School

Jul 2002 - Jun 2004

Bradley Sumrow started working in 2002, then the employee has changed 7 companies and 9 jobs. On average, Bradley Sumrow works for one company for 1 year 8 months.

Their professional focus is Biomarker Development, Clinical Research, and Clinical Study Design across 3 core areas.

Education

MD at University of North Carolina at Chapel Hill School of Medicine

BS at University of North Carolina at Chapel Hill

Certificate at N.C. Governor's School East

Frequently Asked Questions

What is Bradley Sumrow's email address?

SignalHire found verified email addresses for Bradley Sumrow, both business and personal. Their business email is b***@calithera.com, and personal emails include b***@calithera.com, s***@mersana.com, and b***@gmail.com.

What is Bradley Sumrow's phone number?

SignalHire found a verified phone number for Bradley Sumrow: +1-520-***-**52.

How do I contact Bradley Sumrow at Crescent Biopharma?

You can reach Bradley Sumrow through SignalHire by unlocking their verified email and direct phone number (free signup, no credit card needed). SignalHire is the fastest route if you need their contact details immediately.

What is Bradley Sumrow's professional background?

Bradley Sumrow has 24 years of professional experience. They have held roles including Executive Medical Director, Executive Medical Director, and Senior Director of Clinical Research at companies such as Mersana Therapeutics, Calithera Biosciences, and MacroGenics, Inc.. Their education includes MD from University of North Carolina at Chapel Hill School of Medicine, and BS from University of North Carolina at Chapel Hill.

Is Bradley Sumrow's contact information up to date?

Yes. Bradley Sumrow's SignalHire profile was last updated on 8 September 2025, reflecting their current position as Vice President, Clinical Development at Crescent Biopharma.

Similar profiles

Name
Company
Position
Jessica Savage MD
Vice President, Clinical Development
Get contacts
Sun cheng Kang
Vice President, Clinical Development
Get contacts
See more profiles

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP